why choose us

Clinical Trials Search

Showing 15,010 of 132,656 result(s)
A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Status: NOT_YET_RECRUITING

Condition: Glioblastoma

Interventions: Custom-formulated full-spectrum solution high in cannabidiol

Date: 2023-02-10

A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Status: Completed

Condition: Subcutaneous Fat

Interventions: Formulated as an injectable CBL-514 solution at a concentration of 5 mg;mL.

Date: 2023-02-10

Supraspinal Processing of Sensory Aspects of Pain

Status: Completed

Condition: Migraine in Children

Interventions: Reversing checkerboard, tones, and finger opposition.

Date: 2023-02-10

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Status: Completed

Condition: Diabetic Foot Ulcer

Interventions: The COMS One device incorporates technologies for optical and magnetic stimulation.
The optical stimulation component is designed to emit light b

Date: 2023-02-09

Skin Rejuvenation With Topical Extract and Other Nutraceuticals

Status: Completed

Condition: Wrinkle

Interventions: Once daily application of the topical nutraceutical to two by two inch area of skin for 90 days.

Date: 2023-02-09

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

Status: Completed

Condition: Locally Advanced Solid Tumor

Interventions:

Drug: TY-2136b PO, QD or BID

Escalation stage: 7 increased dose cohorts from low dose to MTD (from 40mg QD to 420mg QD)

Date: 2023-02-09

A First-in-human Study of PRTH-101 Monotherapy +;- Pembrolizumab in Subjects With Advanced Malignancies

Status: Completed

Condition: Advanced or Metastatic Solid Tumors

Interventions: PRTH-101 is a humanized immunoglobulin gamma-1 (IgG1) monoclonal antibody

Date: 2023-02-09

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or ?-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Status: Completed

Condition: Sickle Cell Disease

Interventions: PK-guided fludarabine dosing will be used for each of the 2 cycles, using the InsightRx DoseMeRx platform.

Date: 2023-02-09

Virtual Sun Safe Workplaces Ph II (SSW Works)

Status: ACTIVE_NOT_RECRUITING

Condition: Skin Cancer

Interventions: SSW Works is a behavioral, culturally tailored online intervention for skin cancer prevention amongst outdoor workers in the United States.

Date: 2023-02-09